Advancing the Application of Biomarkers & Diagnostics to Enhance the Discovery & Development of Precision Medicines & the Management & Treatment of Complex & Rare Diseases

The inaugural Biomarkers & Diagnostics for Complex & Rare Diseases Summit will unite leading pharma, biotech, Dx and healthcare organizations to advance the application of precision medicine for a range of diseases, including examples from; neurology, cardiovascular, renal, metabolic, dermatology, NASH and rare diseases.

Tackling critical challenges in the discovery, translation, development and commercialization of biomarker-driven and Dx-enabled therapeutics, this meeting will draw on the transferable learnings from a multitude of disease areas to improve treatment decision making and push the boundaries of the standard of care for patients.